AnalystsJeff GarroJeff Garro's Stock Forecasts
AnalystsJeff Garro
Analyst Ranking
Bottom 7%
#3927 out of 4209 analysts
Average Return
-18.88%
Win Rate
36%5 out of 14
Risk vs Reward
Poor
Good
Jeff Garro's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Accolade IncACCD | +144.78% | $5.56 | $13.61 | 2022-04-29 - 2023-03-24 | Strong Buy |
Cerner CorpCERN | +26.50% | $72.75 | $92.03 | 2021-02-16 - 2022-02-15 | Strong Buy |
Alignment Healthcare IncALHC | +17.95% | $8.19 | $9.66 | 2022-02-24 - 2023-02-23 | Strong Buy |
Certara IncCERT | +16.16% | $20.36 | $23.65 | 2022-08-10 - 2023-03-24 | Strong Buy |
Certara IncCERT | +7.06% | $22.09 | $23.65 | 2022-07-01 - 2023-03-24 | Strong Buy |
Jeff Garro Analyst Color
Get additional color on Jeff Garro's coverage of popular stocks
Jeff Garro's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bright Health Group IncBHG | 3 | Strong Buy | $3.00 | +1,263.64% | Maintains | 7 months ago |
Certara IncCERT | 2 | Strong Buy | $25.00 | +5.71% | Maintains | 8 months ago |
Optimizerx CorpOPRX | 2 | Hold | $16.00 | +13.15% | Maintains | 8 months ago |
Alignment Healthcare IncALHC | 3 | Strong Buy | $20.00 | +222.58% | Maintains | 8 months ago |
Veradigm IncMDRX | 3 | Hold | $17.00 | +29.28% | Maintains | 10 months ago |
Innovage Holding CorpINNV | 2 | Strong Sell | $3.90 | -36.79% | Maintains | 10 months ago |
Selectquote IncSLQT | 2 | Hold | $3.00 | +65.75% | Maintains | a year ago |
Accolade IncACCD | 2 | Strong Buy | $11.00 | -19.18% | Maintains | a year ago |
Iqvia Holdings IncIQV | 1 | Strong Buy | $255.00 | +35.39% | Upgrades | a year ago |
Cerner CorpCERN | 1 | Strong Buy | $85.00 | N/A | Maintains | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.